Get started
Author

Patrick J. Miller

Observed names: P.J. Miller, Patrick J Miller, Patrick Miller
ORCID: 0009-0005-8493-850X
Observed ORCID: 0009-0005-8493-850X
OpenAlex ID: A5102890691
The oncogenic fusion protein Pax3–FKHR has a greater post-translational stability relative to Pax3 during early myogenesis
2007 · Patrick J. Miller, Andrew D. Hollenbach · Biochimica et Biophysica Acta (BBA) - General Subjects · 35
FOXO1 stimulates ceruloplasmin promoter activity in human hepatoma cells treated with IL-6
2010 · Alpa Sidhu, Patrick J. Miller, et al. · Biochemical and Biophysical Research Communications · 33
Phosphorylation of Serine 205 by the Protein Kinase CK2 Persists on Pax3-FOXO1, but Not Pax3, throughout Early Myogenic Differentiation
2009 · Kevin N. Dietz, Patrick J. Miller, et al. · Biochemistry · 31
Identification of serine 205 as a site of phosphorylation on Pax3 in proliferating but not differentiating primary myoblasts
2008 · Patrick J. Miller, Kevin N. Dietz, et al. · Protein Science · 28
PDF
The Genomic Organization and Functional Analysis of the Promoter for the Human Angiotensin II Type 1 Receptor
1994 · B.G. Su, M.M. Martin, et al. · Biochemical and Biophysical Research Communications · 26
Identification of CK2 as the kinase that phosphorylates Pax3 at Ser209 in early myogenic differentiation
2012 · Aditi S. Iyengar, Jacob M. Loupe, et al. · Biochemical and Biophysical Research Communications · 18
Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
2024 · Pradeep S. Chauhan, Irfan Alahi, et al. · Clinical Cancer Research · 14
PDF
Phosphorylation of PAX3 contributes to melanoma phenotypes by affecting proliferation, invasion, and transformation
2014 · Aditi S. Iyengar, Patrick J. Miller, et al. · Pigment Cell & Melanoma Research · 9
Acquisition of an oncogenic fusion protein serves as an initial driving mutation by inducing aneuploidy and overriding proliferative defects
2016 · Jacob M. Loupe, Patrick J. Miller, et al. · Oncotarget · 5
PDF
Acquisition of an oncogenic fusion protein is sufficient to globally alter the landscape of miRNA expression to inhibit myogenic differentiation
2017 · Jacob M. Loupe, Patrick J. Miller, et al. · Oncotarget · 4
Novel Flanking DNA Sequences Enhance FOXO1a DNA Binding Affinity but Do Not Alter DNA Bending
2008 · Alpa Sidhu, Patrick J. Miller, et al. · Biochemistry · 4
Isolation of putative FOXO1 genomic elements using an improved in vitro technique to isolate genomic regulatory sequences
2010 · Alpa Sidhu, Patrick J. Miller, et al. · Gene · 1
Supplementary Figure S3 from Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
2025 · Pradeep S. Chauhan, Irfan Alahi, et al.
Supplementary Figure S1 from Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
2025 · Pradeep S. Chauhan, Irfan Alahi, et al.
Supplementary Figure S9 from Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
2025 · Pradeep S. Chauhan, Irfan Alahi, et al.
Supplementary Figure S11 from Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
2025 · Pradeep S. Chauhan, Irfan Alahi, et al.
Supplementary Figure S2 from Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
2025 · Pradeep S. Chauhan, Irfan Alahi, et al.
Supplementary Figure S7 from Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
2025 · Pradeep S. Chauhan, Irfan Alahi, et al.
Data from Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
2025 · Pradeep S. Chauhan, Irfan Alahi, et al.
Supplementary Figure S8 from Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
2025 · Pradeep S. Chauhan, Irfan Alahi, et al.
Supplementary Figure S5 from Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
2025 · Pradeep S. Chauhan, Irfan Alahi, et al.
Supplementary Figure S6 from Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
2025 · Pradeep S. Chauhan, Irfan Alahi, et al.
Supplementary Figure S4 from Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
2025 · Pradeep S. Chauhan, Irfan Alahi, et al.
Supplementary Figure S10 from Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
2025 · Pradeep S. Chauhan, Irfan Alahi, et al.
Supplementary Table S1-S14 from Genomic and Epigenomic Analysis of Plasma Cell-Free DNA Identifies Stemness Features Associated with Worse Survival in Lethal Prostate Cancer
2025 · Pradeep S. Chauhan, Irfan Alahi, et al.
Works count: 29
Citation count: 208
H-index: 8
I10-index: 7
Year
Topic
Type